If Moderna's CEO Is Right, the Stock's Rally Could Just Be Getting Started
· fool.com · popularity 20/100 · 0 similar stories today · Cancer & Oncology (Health & Life Sciences)
Read the original at fool.com →
Summary
Stéphane Bancel has high hopes for the company's cancer vaccine, beyond just treating melanoma. Moderna (MRNA +2.54%) has been the hottest stock in …
Found in: The Motley Fool. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 5.